Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-14, Stock:LLY, The news for the past five days is as follows:
2020-12-07: NEWS1: Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN Clinical Trial for LOXO-305 in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma at the American Society of Hematology Annual Meeting.NEWS2: Lilly (LLY)/UnitedHealth Launch COVID-19 Study on Bamlanivimab.NEWS3: AbCellera Biologics sets terms of IPO, which could value the company at up to $4.5 billion.NEWS4: Thiel-backed therapy developer AbCellera looks to raise up to $391 mln in IPO.
2020-12-08: NEWS1: Vaccines Alone Aren’t Enough to Beat Covid-19.NEWS2: Is LLY A Good Stock To Buy Now?.NEWS3: Lilly Confirms Date and Conference Call for 2021 Financial Guidance Announcement.NEWS4: Should You Be Adding Eli Lilly (NYSE:LLY) To Your Watchlist Today?.
2020-12-09: NEWS1: Why Eli Lilly Stock Jumped Today.NEWS2: How Eli Lilly's Newest Drug Took Weight Off Patients — And Lilly Shares.NEWS3: Lilly Jumps After Results From Next Generation Diabetes Drug.NEWS4: Here's Why A Relief Rally Sent Eli Lilly Stock To A 4-Month High.NEWS5: Roche (RHHBY), Moderna Ink Deal for Coronavirus Antibody Test.NEWS6: Eli Lilly Sees Positive Data From Late-Stage Trial of Diabetes Treatment Tirzepatide.NEWS7: Lilly Presents Positive Primary Outcome Data from monarchE that Builds on Previous Definitive Analysis for Verzenio®.NEWS8: Lilly's tirzepatide significantly reduced A1C and body weight in people with type 2 diabetes.
2020-12-10: NEWS1: Lilly's (LLY) Tirzepatide Meets Endpoints in Late-Stage Study.NEWS2: Company News for Dec 10, 2020.NEWS3: Thiel-backed antibody therapy developer AbCellera boosts IPO price range.NEWS4: Eli Lilly (LLY) Soars: Stock Adds 5.8% in Session.
2020-12-11: NEWS1: Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know.NEWS2: Thiel-Backed Developer of Covid-19 Therapy Surges in Debut.NEWS3: COVID SCIENCE-Drug combination improves COVID-19 pneumonia outcomes; five genes linked to severe disease.NEWS4: Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine.NEWS5: Five key severe COVID-19 genes found, suggesting drug targets.NEWS6: Pharma Stock Roundup: FDA Panel's Nod to PFE/BNTX Coronavirus Vaccine, Other Updates.

Answer: Decrease